Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Urology. 2012 Dec;80(6):1236–1242. doi: 10.1016/j.urology.2012.09.006

Figure 1. Probability of IMRT adoption according to managed care penetration.

Figure 1

Throughout the study, high managed care markets demonstrated a greater propensity for IMRT adoption compared to low managed care markets (p=0.05).

HSA, health service area; IMRT, intensity-modulated radiotherapy

*Adjusted for patient-level (i.e., age, tumor grade and stage, and comorbidity) and market-level characteristics (i.e., racial composition, population density, education, income, percent speaking English as a secondary language, number of hospital beds and radiation oncologists in a market, and SEER region).